Netherlands· NL-60b4de8d82e6
Sitagliptine Viatris 50 mg, filmomhulde tabletten
A sitagliptin product containing sitagliptinehydrochloride, registered in Netherlands by Viatris Limited. The same ATC class is registered in 19 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Sitagliptin is registered in 19 of 19 countries.
Countries holding a registration under ATC A10BH01 (sitagliptin), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 11 of them publish a price we can compare per daily dose
Sitagliptin · ATC A10BH01
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of sitagliptin costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), the median price runs from $0.65 in France to $5.47 in Switzerland — a ×8.4 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Sitagliptin · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- CH Switzerland$5.47
- IT Italy$1.78
- ES Spain$1.08
- FR France$0.65
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- SITAGLIPTINEHYDROCHLORIDE
- Manufacturer
- Viatris Limited
- Country
- Netherlands (NL)
- ATC code
- A10BH01
- ATC class
- Sitagliptin
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id126170
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
341 interactions on record for sitagliptin.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sitagliptin · interactions on record
341 records
- 3 severe
- 292 moderate
- 44 minor
Most severe, free to view
- GatifloxacinJ01MA16severe
- SucralfateA02BX02moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sitagliptin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaANSIFORAVipharm S.A., Ożarów Mazowiecki
- SpainALTUXERIN 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGBexal Farmaceutica S.A.
- PolandAdimuplanSandoz GmbH
- SwedenAxavel 50 mg Filmdragerad tablettGenepharm S.A.
- FinlandFineriaMedical Pharmaquality SA
- BelgiumJanumet 50 mg - 1000 mgMerck Sharp & Dohme
- ItalyADAGLIPADAMED S.R.L.
- FranceJANUVIA 50 mg, comprimé pelliculéMERCK SHARP & DOHME (PAYS-BAS)
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Jansitin, Jazeta
- Belgium · Sitagliptin Eg, Sitagliptin Grindeks
- Bulgaria · Sitagliptin Grindeks, Майсиглу
- Cyprus · Jidinum, Jimandin
- Czechia · Anau, Ansifora
- Germany · Frekidir, Jansitin
- Denmark · Frekidir, Meliglix
- Estonia · Adimuplan, Maysiglu
- Spain · Altuxerin, Disit
- Finland · Sitagliptin Apc Instytut, Sitagliptin Ashcure
- France · Sitagliptine Adamed, Sitagliptine Almus
- United Kingdom (Northern Ireland) · Sitagliptin, Sitagliptin Amarox
- Greece · Adimuplan, Axavel
- Croatia · Adimuplan, Condias
- Hungary · Ansifora, Jaglix
- Ireland · Sitagliptin Grindeks, Sitagliptin Krka
- Iceland · Januvia, Ristaben
- Italy · Adaglip, Andamane
- Liechtenstein · Januvia, Ristaben
- Lithuania · Adimuplan, Jimandin
- Luxembourg · Sitagliptin Eg
- Latvia · Adimuplan, Jimandin
- Malta · Anau, Jidinum
- Norway · Frekidir, Januvia
- Poland · Ansifora, Jansitin
- Portugal · Itam, Jidinum
- Romania · Adimuplan, Jansitin
- Sweden · Axavel, Frekidir
- Slovenia · Adimuplan, Maysiglu
- Slovakia · Adimuplan, Anau
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b2309abe-e006-4827-ab74-153954ae47b1 GET /v1/drugs/b2309abe-e006-4827-ab74-153954ae47b1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h126170_smpc.pdf",
"strength": null,
"atc_label": "Sitagliptin",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg126170",
"excipients": [
"CALCIUMWATERSTOFFOSFAAT 0-WATER (E 341)",
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"CROSCARMELLOSE NATRIUM (E 468)",
"IJZEROXIDE GEEL (E 172)",
"IJZEROXIDE ROOD (E 172)",
"MACROGOL 3350",
"MAGNESIUMSTEARAAT (E 470b)",
"POLYVINYLALCOHOL (E 1203)",
"SILICIUMDIOXIDE (E 551)",
"TALK (E 553b)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"SITAGLIPTINEHYDROCHLORIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h126170.pdf",
"authorised_at": "2021/08/11",
"procedure_number": "DK/H/3146/002",
"dispensing_status": "Uitsluitend recept",
"registration_number": "126170",
"additional_monitoring": "N"
}See everything about sitagliptin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.